baber/WOPTO huggingface dataset:
Patent ES-2890491-T1 (ES)
Title: Descolonización específica de bacterias resistentes a los antibióticos para fines profilácticos
Inventor: DUPORTET XAVIER
IPC: C12N15/10
Filed: 2021-06-14
Abstract: Un vector para usar en un método de eliminación selectiva de la resistencia a antibióticos de una cepa(s) bacteriana(s) resistente(s) a antibióticos en un sujeto sano portador de cepa(s) bacteriana(s) resistente(s) a antibióticos o en un paciente portador de cepa(s) bacteriana(s) resistente(s) a antibióticos, en donde dicho vector codifica una enzima modificadora de ADN que inactiva el(los) gen(es) de resistencia a antibióticos responsable(s) de la resistencia a antibióticos de la(s) cepa(s) bacteriana(s), eliminando así selectivamente la resistencia a antibióticos de una cepa(s) bacteriana(s) resistente(s) a antibióticos en la microbiota de dicho sujeto o paciente.
Patent CY-1110602-T1 (CY)
Title: Φαρμακευτικες συνθεσεις υπο μορφη γελης ή διαλυματος με βαση τη διυδροτεστοστερονη, μεθοδοι παρασκευης και χρησεις τους
Inventor: MASINI-ETEVE VALERIE
IPC: A61P5/24
Filed: 2009-10-30
Abstract: Η παρούσα ευρεσιτεχνία αφορά φαρμακευτική σύνθεση που παρουσιάζεται υπό τη μορφή γέλης ή διαλύματος και χαρακτηρίζεται από το ότι περιέχει διυδροτεστοστερόνη καθώς επίσης και τουλάχιστον ένα υποκινητή διείσδυσης, τις μεθόδους παρασκευής της και τις χρήσεις της.
Patent CY-1110690-T1 (CY)
Title: Ενωσεις 4-οξοκινολινης και χρησιμοποιηση αυτων ως αναστολεις της ενσωματασης του hiv
Inventor: SATOH MOTOHIDE
IPC: C07D471/04
Filed: 2009-12-11
Abstract: Εδώ περιγράφεται ένας αντι-HIV παράγοντας που περιέχει, ως ένα δραστικό συστατικό, μια ένωση 4-οξοκινολίνης που παριστάνεται με τον ακόλουθο τύπο (I) όπου κάθε σύμβολο έχει όπως ορίζεται στη λεπτομερή περιγραφή της ευρεσιτεχνίας, ή ένα φαρμακευτικώς αποδεκτό άλας αυτής. Η ένωση της παρούσας εφεύρεσης έχει ανασταλτική της ενσωμάτωσης του HIV δράση και είναι χρήσιμη ως ένας αντι-HIV παράγοντας για την προφύλαξη από ή τη θεραπεία του AIDS. Επιπλέον, με τη συνδυασμένη χρήση με άλλους αντι-HIV παράγοντες όπως αναστολείς πρωτέασης, αναστολείς αντίστροφης τρανσκριπτάσης και τα παρόμοια, η ένωση μπορεί να καταστεί ένας πιο αποτελεσματικός αντι-HIV παράγοντας. Εφόσον η ένωση έχει υψηλή ανασταλτική δραστικότητα ειδική για τις ενσωματάσες, μπορεί να προσφέρει έναν ασφαλή φαρμακευτικό παράγοντα με λιγότερες παρενέργειες για τον άνθρωπο.
Patent CY-1110703-T1 (CY)
Inventor: SHAH MANDAR V
IPC: A61K38/14
Filed: 2010-03-19
Abstract: Improved intraocular irrigating solutions are described. The solutions have enhanced viscosities that reduce the risk of damage to intraocular tissues during intraocular surgical procedures by reducing the turbulence of the solutions and dampening the movement of tissue fragments and air bubbles. The solutions preferably also have modified surface tensions that more closely resemble the surface tension of the aqueous humor.
Patent CY-1110692-T1 (CY)
Inventor: KANG SEUNG-YEON
IPC: H04N13/00
Filed: 2010-04-19
Abstract: The present invention is related to a method for recording three dimensional video, and a movie camera which intend to allow recording of images in stereoscopic 3-D that can be watched with naked single eye without 3-D eyewear. The method and 3-D camera makes it possible to record 3-D images, that can be perceived three-dimensionally with human eye alone, which have the same color and brightness of images recorded in 2-D.
Patent CY-1112453-T1 (CY)
Title: Αντιϊικες ενωσεις
Inventor: CHAUDHARY KLEEM
IPC: C07F9/141
Filed: 2011-10-10
Abstract: Η εφεύρεση αφορά υποκατεστημένες με φωσφόρο αντι-ιικές ανασταλτικές ενώσεις, συνθέσεις που περιέχουν τέτοιες ενώσεις και θεραπευτικές μεθόδους που περιλαμβάνουν τη χορήγηση τέτοιων ενώσεων, καθώς επίσης μεθόδους και ενδιάμεσα χρήσιμα για παρασκευή τέτοιων ενώσεων.
Patent CY-1113058-T1 (CY)
Title: Συνδυαστικη θεραπεια για την αντιμετωπιση οφθαλμικων νεοαγγειακων διαταραχων
Inventor: SHIMA DAVID
IPC: A61K31/00
Filed: 2012-08-02
Abstract: Η εφεύρεση παρουσιάζει μεθόδους για αγωγή ενός ασθενούς ο οποίος έχει διαγνωστεί με, ή βρίσκεται σε κίνδυνο για ανάπτυξη, μιας νεοαγγειακής διαταραχής με χορήγηση ενός PDGF ανταγωνιστή και ενός VEGF ανταγωνιστή στον ασθενή. Η εφεύρεση επίσης παρουσιάζει μια φαρμακευτική σύνθεση η οποία περιέχει έναν ΡDGF ανταγωνιστή και ένα VEGF ανταγωνιστή για την αντιμετώπιση ή πρόληψη μιας νεοαγγειακής διαταραχής.
Patent CY-1113495-T1 (CY)
Title: Χρηση μιας συνθεσης που περιλαμβανει μια ενωση υδροκινονης, ακετονιδιου φθοριοκινολονης και τρετινοϊνης, που προοριζεται για τη θεραπεια δερματικων σημαδιων φωτογηρανσης
Inventor: HEXSEL DORIS MARIA
IPC: A61K8/67
Filed: 2012-12-21
Abstract: Η παρούσα εφεύρεση αναφέρεται σε μία δερματολογική σύνθεση που περιλαμβάνει μία ένωση υδροκινόνης, ακετονιδίου φθοριοκινολόνης και τρετινοΐνης, που προορίζεται για την θεραπεία δερματικών σημαδιών φωτογήρανσης.
Patent CY-1115880-T1 (CY)
Title: Μια αμορφη και μια κρυσταλλικη μορφη gενζ 112638 ηεμιταrτrατε ως αναστολεας συνθετασης γλυκοζυλοκεραμιδιου
Inventor: LIU HANLAN
IPC: A61K31/4025
Filed: 2014-08-28
Abstract: Αποκαλύπτεται το ημιτρυγικό άλας μιας ένωσης που αντιπροσωπεύεται από τον συγκεκριμένο δομικό τύπο: (Τύπος Ι Ημιτρυγικό), που μπορεί να χρησιμοποιηθεί σε φαρμακευτικές εφαρμογές. Συγκεκριμένες μοναδιαίες κρυσταλλικές μορφές του Τύπου (Ι) Ημιτρυγικού χαρακτηρίζονται από μια ποικιλία ιδιοτήτων, και φυσικών μετρήσεων. Καθώς και, μέθοδοι παραγωγής κρυσταλλικού Τύπου (Ι) Ημιτρυγικού, και χρήσης του για την αναστολή της συνθετάσης γλυκοζυλοκεραμιδίου ή τη μείωση των συγκεντρώσεων γλυκοσφιγγολιπιδίων σε υποκείμενα προς θεραπεία σε έναν αριθμό ασθενειών, συζητώνται επίσης. Επίσης περιγράφονται φαρμακευτικές συνθέσεις.
Patent CY-1118437-T1 (CY)
Title: Στοχευομενη απελευθερωση φαρμακων θεραπευτικων νουκλεϊνικων οξεων και λειτουργικων νουκλεϊνικων οξεων σε κυτταρα θηλαστικου μεσω ανεπαφων θανατωμενων βακτηριακων κυτταρων
Inventor: BRAHMBHATT HIMANSHU
IPC: A61K39/00
Filed: 2017-01-05
Abstract: Σύνθεση περιλαμβάνουσα ανέπαφα θανατωμένα βακτηριακά κύτταρα που περιέχουν θεραπευτικό νουκλεϊνικό οξύ, φάρμακο ή λειτουργικό νουκλεϊνικό οξύ είναι χρήσιμη για στοχευόμενη απελευθέρωση σε κύτταρα θηλαστικού. Η στοχευόμενη απελευθέρωση προαιρετικώς χρησιμοποιεί διπλά-ειδικά εκλεκτικούς συνδέτες, που περιλαμβάνουν έναν πρώτο βραχίονα που φέρει ειδικότητα για δομή επιφανείας θανατωθέντος βακτηριακού κυττάρου και έναν δεύτερο βραχίονα που φέρει ειδικότητα για υποδοχέα επιφανείας κυττάρου θηλαστικού, σε στοχευόμενα θανατωμένα βακτηριακά κύτταρα προς συγκεκριμένα κύτταρα θηλαστικού και για να προκαλεί ενδοκυττάρωση των θανατωμένων βακτηριακών κυττάρων από τα κύτταρα θηλαστικού. Εναλλακτικώς, η μέθοδος απελευθέρωσης εκμεταλλεύεται την φυσική ικανότητα φαγοκυτταρικών κυττάρων θηλαστικού να καταβροχθίζουν θανατωμένα βακτηριακά κύτταρα χωρίς την χρήση διπλά-ειδικών εκλεκτικών συνδετών.
Patent CY-1122995-T1 (CY)
Title: Συσκευη για την κωδικοποιηση μιας εικονας
Inventor: OH SOO MI
IPC: H04N19/117
Filed: 2019-05-09
Abstract: Μια συσκευή για την κωδικοποίηση μιας εικόνας περιλαμβάνει μια μονάδα ένδο- πρόβλεψης που έχει διαμορφωθεί για να ορίζει μια κατάσταση ένδο- πρόβλεψης, για την παραγωγή pixel αναφοράς που αντιστοιχούν σε διαθέσιμα pixel αναφοράς, για το προσαρμοστικό φιλτράρισμα των pixel αναφοράς σύμφωνα με την κατάσταση ένδο- πρόβλεψης, και για την παραγωγή ενός μπλοκ πρόβλεψης με χρήση των pixel αναφοράς που ορίζονται από την κατάσταση ένδο- πρόβλεψης.
Patent CY-1124000-T1 (CY)
Title: Υποκατεστημενες 5-φθορο-1η-πυραζολοπυριδινες σε κρυσταλλικη μορφη
Inventor: FEY PETER
IPC: C07D471/04
Filed: 2021-03-26
Abstract: Η παρούσα εφεύρεση αναφέρεται σε υποκατεστημένες 5-φθορο-1Η-πυραζολοπυριδίνες του τύπου (Ι) σε κρυσταλλική μορφή με πλείστες τροποποιήσεις ή διαλύματα, καθώς και στις διαδικασίες παρασκευής τους και στη χρήση τους για την παρασκευή φαρμακευτικών μέσων για τη θεραπευτική αντιμετώπιση και/ή για την πρόληψη καρδιοαγγειακών νοσημάτων.
Patent HR-P20110071-T1 (HR)
Inventor: SCHIPS CARSTEN
IPC: C08J9/18
Filed: 2011-01-31
Abstract: Termoplastična čestična pjena sa stanicama čija je srednja veličina u rasponu od 20 do 500 µm, naznačena time što su stanične membrane nanostanične ili vlaknaste strukture s promjerom pora ili vlakna manjim od 1500 nm. Patent sadrži još 8 patentnih zahtjeva.
Patent HR-P20110088-T1 (HR)
Title: Box-shaped device for holding water, such as a rainwater box, and method for using the same
Inventor: HOEKSTRA HIELKE DOLF
IPC: E03F1/00
Filed: 2011-02-03
Abstract: A box-shaped device for holding water, such as a rainwater box, comprising at least four partially open side walls and a panel extending between the side walls and having a rectangular shape, the width of which is half the length. The panel is provided with an inspection passage which is positioned centrally in one of the two square panel halves of the panel defined by the rectangular shape, so that whenever the rainwater boxes are stacked, a vertical passage is always provided for passing through, for example, an inspection camera.
Patent HR-P20110486-T1 (HR)
Title: A dispenser and composition to make ice coffee
Inventor: KERSTENS PETER
IPC: B65D83/14
Filed: 2011-07-01
Abstract: A holder to dispense and prepare as coffee, consisting of a first compartment containing liquid coffee extract, a second compartment containing a propellant, a nozzle with a valve, and whereby at least one additive, such as sugars, sweeteners, aromas or a combination thereof, can be added to the concentrate in order to spray a jet of product onto a liquid.
Patent HR-P20110504-T1 (HR)
Title: Agent and method for tanning skins and pelts
Inventor: ZOTZEL JENS
IPC: C14C3/12
Filed: 2011-07-06
Abstract: Method for tanning skin and fur, comprises treating the skin and fur with tanning agent comprising deglycosylated iridoid and/or deglycosylated secoiridoid. An independent claim is included for a tanning agent containing 0.1-25 wt.% of deglycosylated secoiridoid and/or its mixture.
Patent HR-P20110525-T1 (HR)
Inventor: NEATE ANDREW SIMON
IPC: H01J65/04
Filed: 2011-07-12
Abstract: Svjetlosni izvor na mikrovalnu energiju, pri čemu svjetlosni izvor: a)	sadrži tijelo koje u sebi ima hermetički zatvorenu šupljinub)	mikrovalni Faradayev kavez (18) koji okružuje tijelo, a.	tijelo unutar Faradayevog kaveza je rezonantni valovod, c)	šupljina je ispunjena s tvari koju mikrovalna energija može pobuditi tako da se u njoj stvara plazma koja emitira svjetlo, id)	sadrži antenu (20, 22) koja je postavljena unutar tijela u svrhu prijenosa mikrovalne energije koja može stvoriti plazmu u tvari koja ispunjava šupljinu, pri čemu antena sadrži: a.	priključak koji izlazi iz tijela za priključivanje na izvor mikrovalne energije; naznačen time, daa)	tijelo je kruta plazmena retorta (11) tvari koja je prozirna tako da propušta svjetlo koje iz njega izlazi, ib)	Faradayev kavez može bar djelomično prenositi svjetlo koje izlazi iz plazmene retorte, sklop je izrađen na način da svjetlo iz plazme u šupljini može proći kroz plazmenu retortu i širiti se iz nje kroz kavez. Patent sadrži još 20 patentnih zahtjeva.
Patent HR-P20110646-T1 (HR)
Title: Aripiprazole injectable suspension
Inventor: BROWN JOSIAH
IPC: A61K47/38
Filed: 2011-09-07
Abstract: The present invention relates, in part, to the discovery that a pharmaceutical composition comprising aripiprazole and a carrier administered in a bolus injection resulted in an extended release profile similar to that obtained by the injection of a polylactide-co-glycolide microsphere formulation containing the active agent. This surprising result provides pharmacologically beneficial extended release formulations without the complexities and expense associated with the manufacture of microspheres.
Patent SI-1147088-T1 (SI)
Title: 6-arylphenanthridines with pde-iv inhibiting activity
Inventor: FLOCKERZI DIETER
IPC: A61K31/00
Filed: 2000-01-12
Abstract: Compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51 and Ar have the meanings indicated in the description, are novel active bronchial therapeutics.
Patent SI-1805169-T1 (SI)
Title: Histamine h3 receptor inhibitors, their preparation and therapeutic uses
Inventor: JESUDASON CYNTHIA DARSHINI
IPC: A61K31/00
Filed: 2005-10-11
Abstract: The present invention provides novel compounds with histamine-H3 receptor antagonist or inverse agonist activity. In particular, the invention provides a compound of Formula I, or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the compounds, methods of treatment employing these compounds and compositions, and intermediates and methods for making these compounds. The invention provides methods of using compounds and pharmaceutical compositions to treat obesity, cognitive deficiences, narcolepsy, and other histamine H3 receptor-related diseases.
Patent SI-1899508-T1 (SI)
Title: Crucible for the crystallization of silicon and process for its preparation
Inventor: RANCOULE GILBERT
IPC: C30B11/00
Filed: 2006-06-30
Abstract: The invention relates to a crucible for the crystallization of silicon and to the preparation and application of release coatings for crucibles used in the handling of molten materials that are solidified in the crucible and then removed as ingots, and more particularly to release coatings for crucibles used in the solidification of polycrystalline silicon. The objective of the inventor was to provide a crucible which does not require the preparation of a very thick coating at the end user facilities, which is faster and cheaper to produce and which presents an improved release effect and which allows the production of silicon ingot without cracks. It has now been found that these problems can be solved with a crucible for the crystallization of silicon comprising a) a base body comprising a bottom surface and side walls defining an inner volume; b) a substrate layer compnsing 80 to 100 wt. % of silicon nitride at the surface of the side walls facing the inner volume 
c) an intermediate layer comprising 50 to 100 wt. % of silica on the top of the substrate layer; and d) a surface layer comprising 50 to 100 wt. % of silicon nitride, up to 50 wt. % of silicon dioxide and up to 20 wt % of silicon on the top of the intermediate layer.
Patent SI-1858328-T1 (SI)
Title: Herbicidal composition
Inventor: GREINER ANJA
IPC: A01N43/80
Filed: 2006-03-17
Abstract: A herbicidal composition comprising;(A) 3-[[[5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl]-sulfonyl]-4,5-dihydro-5,5-dimethyl-isoxazole, or a herbicidally effective salt; and(B) a second herbicide selected from;(B1) 4-hydroxy-3-[[2-[(2-methoxyethoxy)methyl]-6-(trifluoromethyl)-3-pyridinyl]carbonyl]-bicyclo[3.2.1]oct-3-en-2-one,(B2) tembotrione, and(B3) topramezone,or their herbicidally effective salts.
Patent SI-2443407-T1 (SI)
Title: Method for adjusting an oven for baking anodes, and oven suitable for implementing same
Inventor: MORALES FRANCOIS
IPC: F27D21/00
Filed: 2010-06-07
Abstract: The invention relates to a method for adjusting an oven for baking carbon anodes, including: longitudinal hollow walls in each of which a baking hot gas stream can flow, the hollow walls defining cells therebetween for receiving the anodes to be baked, and a heating system rotating relative to the hollow walls and including an upstream manifold for blowing air into the various walls, a downstream manifold for drawing the gas from the various walls, and at least one heating manifold. The method includes a phase of naturally preheating the walls and the anodes which release volatile combustible materials that burn in the hollow cells as a degassing front in a natural preheating area of the oven downstream from the heating manifold. According to the invention, the method comprises modifying the gas stream flowing in the hollow walls so as to control the gas streams (30, 31) passing through a first natural preheating area using the gas streams (31) exiting a second natural preheating area (Z2) in order to control the positioning of the degassing front.
Patent DE-3750314-T2 (DE)
Inventor: FORSE NICHOLAS JOHN ARNOLD
IPC: H04W88/02
Filed: 1987-05-29
Granted: 1994-11-17
Abstract: In a speech processor such as a speech recogniser, the problem of detecting the beginning and end of speech or a word accurately, to enable the creation of a speech or a word template which consistently matches stored speech or word templates is solved by characterising background noise and forming a background noise template, setting a speech threshold above which speech is detected and stored, and subtracting the background noise template from the stored speech to form a speech template. <IMAGE>
Patent DE-3850810-T2 (DE)
Inventor: O'LEARY RAYMOND P
IPC: H01H33/16
Filed: 1988-05-18
Granted: 1994-11-17
Abstract: An impedance arrangement (10) is provided for use in a high-voltage circuit. For example, the impedance arrangement (10) is useful in a circuit which includes reactance elements (e.g., 52) and a high-voltage circuit-switching device (e.g., 50). The impedance arrangement (10) limits transient inrush current and/or voltages in a first frequency range (e.g., 200-750 hz) which occur in the circuit during closure of the circuit-switching device and damps transients in a second frequency range (e.g., 10-200 khz) which occur in the circuit during opening of the circuit-switching device (50). The impedance arrangement (10) is also useful in applications requiring tuning reactors and current-limiting reactors to limit abnormal power-frequency currents, harmonics, transients, and/or high-frequency inrush currents. The impedance arrangement (10) functions predominantly as an inductive impedance over the first frequency range (200-750 hz); e.g., corresponding to the frequencies of transients encountered during the closing of the circuit-switching device. Additionally, the impedance arrangement (10) functions predominantly as a resistance over the second frequency range (10-200 khz) which is higher than the first frequency range (200-750 hz); e.g., corresponding to the frequencies of transient conditions on a power system such as are encountered during the opening of the circuit-switching device. The impedance arrangement comprises a first winding (12) having a first predetermined inductance (L1) and a second winding (14) connected in parallel with the first winding (12). The second winding (14) has a second predetermined inductance (L2) and a second predetermined resistance (R2). The second winding (14) is wound with respect to the first winding in an opposite sense to the first winding (12) and so to define a predetermined mutual inductance (Lm) between the first (L1) and second (L2) inductances.
Patent DE-3854687-T2 (DE)
Inventor: CUMMINGS FREDERICK LEON
IPC: C09D5/03
Filed: 1988-08-10
Granted: 1996-05-02
Abstract: Unsaturated polyester resin coating powder composition consisting essentially of at least one unsaturated polyester resin; at least one copolymerizable second resin; and an initiator which comprises 1,1 min -di(t-butylperoxy)-3,3,5-trimethylcyclohexane (AE), or which contains a small proportion of a fast initiator and a relatively large proportion of a slow initiator as defined herein. A method is also disclosed for forming a cured unsaturated polyester surface coating on a cured unsaturated polyester substrate by coating one of the previously stated powder compositions on a heated mold surface so the coating flows and coalesces to form a partially crosslinked coating, then putting a charge of reinforced polyester resin in the mold and closing the mold, maintaining a suitable pressure and temperature for a time sufficient to cure the fill resin and the coating. The coating and substrate are crosslinked across the interface between them when the part is cured.
Patent DE-3855798-T2 (DE)
Inventor: ARAI HIROSHI NIPPON METAL IND
IPC: C22C38/22
Filed: 1988-05-24
Granted: 1997-06-12
Abstract: This invention provides subzero treatment hardening type martensitic stainless steels which comprise not more than 0.4 % by weight of C, not more than 0.4 % by weight of Mn, not more than 3.0 % by weight of Ni, 10 to 23 % by weight of Cr, not more than 3.0 % by weight of Mo, not more than 2.0 % by weight of Cu, not more than 2.0 % by weight of Si and the remaining portion consists of inevitable impurities and Fe, and satisfy the following formulae (1), (2) and (4), ÄCr %Ü + 1.5 ÄSi %Ü + ÄMo %Ü - ÄMn %Ü - 1.3 ÄNi %Ü - ÄCu %Ü - 19 ÄC %Ü - 19 ÄN %Ü </= 12.0 27.5 </= ÄCr %Ü + 1.3 ÄSi %Ü + 1.3 ÄMn %Ü + 1.5 ÄNi %Ü + ÄCu %Ü + ÄMo %Ü + 15 ÄC %Ü + 20 ÄN %Ü </= 32.0 1.3 ÄNi %Ü + ÄMn %Ü + ÄCu %Ü </= 4.0
Patent DE-3880824-T2 (DE)
Inventor: GIBSON DAVID
IPC: A61F2/16
Filed: 1988-11-09
Granted: 1993-10-14
Abstract: Prosthetic devices are prepared for subepithelial implantation by coating their surfaces with a coating (30) comprising crosslinked or uncrosslinked fibronectin. If the surface of the device comprises a material which does not normally bind fibronectin, it is pretreated, for example, by coating with poly(L-lysine). The coated prosthetic device is implanted by removing a portion of the epithelium (12), affixing the coated device to the subepithelial tissue optionally replacing all or part of the removed epithelium, and allowing new epithelial tissue to grow over and affix itself to the surface of the prosthetic device. The method of the invention can be used to implant contact lenses permanently beneath the epithelium of the cornea (10).
Patent DE-3881884-T2 (DE)
Inventor: KING RICHARD
IPC: G07F7/00
Filed: 1988-04-14
Granted: 1993-11-11
Abstract: A machine primarily for renting articles, e.g. video cassettes by the use of a club card and in which there is provided a memory (29) in which is recorded a card credit or a credit limit for a user of the machine when the user first passes the club card through a card reader on the machine, renting transactions being arranged to reduce the card credit in the memory.
Patent DE-3882297-T2 (DE)
Inventor: COLBORN DAVID W
IPC: C11D17/04
Filed: 1988-08-02
Granted: 1993-10-21
Abstract: A homogeneous fragrance preblend for liquid bleaches comprises     (a) about 0.15-15% fragrance   (b) about 1-25% hydrotrope   (c) about 0.001-0.09% surfactant; and   (d) water and miscellaneous minors as the remainder.   A method of making such preblends is also disclosed. Such preblends are of use in the fragrancing of liquid bleaches.
Patent DE-3888868-T2 (DE)
Inventor: ORMSBY MARY ELIZABETH
IPC: C08K5/00
Filed: 1988-05-16
Granted: 1994-08-25
Abstract: A process for producing a polyurethane plastics having photochromic properties, characterised in that the process comprises in a first step incorporating a reversible cleavage photochromic compound into at least one di-isocyanate compound or at least one polyol or a mixture of a di-isocyanate and one or more polyols or into any other component of a mixture which, when polymerised, will yield a polyurethane; combining the mixture from the first step with any other necessary components to enable polymerisation to occur; and polymerising the resultant mixture to form a polyurethane incorporating the said photochromic compound. The photochromic polyurethane plastics of the invention are useful as intermediate layers in glass or plastics laminates for architectural applications or for use in vehicle windows or roof-lights.
Patent TR-199802419-T2 (TR)
Inventor: BANTICK JOHN
IPC: A61K31/506
Filed: 1997-05-20
Abstract: Bulus, kaynasmis piridazin bilesikleri ile, özellikle de pirido[h]kinolin, pirido[h]kinolinon, piridosiklopenta [1,2-c]piridazin, piridosiklopenta [1,2-c]piridazinon, piridosiklohepta[1,2-c]piridazin ve piridosiklohepta [1,2-c]piridazinon türevleri ile, bunlarin ilaç olarak kullanimi ve bunlari kapsayan farmasötik bilesimler ile ilgilidir.